126 related articles for article (PubMed ID: 18592827)
1. Efficacy of nasal Staphylococcus aureus eradication by topical nasal mupirocin in patients with perennial allergic rhinitis.
Zeldin Y; Weiler Z; Cohen A; Kalinin M; Schlesinger M; Kidon M; Magen E
Ann Allergy Asthma Immunol; 2008 Jun; 100(6):608-11. PubMed ID: 18592827
[TBL] [Abstract][Full Text] [Related]
2. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
3. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome.
Talpur R; Bassett R; Duvic M
Br J Dermatol; 2008 Jul; 159(1):105-12. PubMed ID: 18489588
[TBL] [Abstract][Full Text] [Related]
5. Nasal carriage of Staphylococcus aureus in house dust mite allergic patients and healthy controls.
Riechelmann H; Essig A; Deutschle T; Rau A; Rothermel B; Weschta M
Allergy; 2005 Nov; 60(11):1418-23. PubMed ID: 16197475
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin.
Pérez-Fontán M; Rosales M; Rodríguez-Carmona A; Moncalián J; Fernández-Rivera C; Cao M; Valdés F
Adv Perit Dial; 1992; 8():242-5. PubMed ID: 1361797
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations.
Solares CA; Batra PS; Hall GS; Citardi MJ
Am J Otolaryngol; 2006; 27(3):161-5. PubMed ID: 16647979
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
Dupeyron C; Campillo B; Richardet JP; Soussy CJ
J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
[TBL] [Abstract][Full Text] [Related]
9. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
11. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection.
Raz R; Miron D; Colodner R; Staler Z; Samara Z; Keness Y
Arch Intern Med; 1996 May; 156(10):1109-12. PubMed ID: 8638999
[TBL] [Abstract][Full Text] [Related]
12. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients.
Souly K; Ait el kadi M; Lahmadi K; Biougnach H; Boughaidi A; Zouhdi M; Benasila S; Elyoussefi Z; Bouattar T; Zbiti N; Skalli Z; Rhou H; Ouzeddoun N; Bayahia R; Benamar L
Med Mal Infect; 2011 Sep; 41(9):469-74. PubMed ID: 21752563
[TBL] [Abstract][Full Text] [Related]
14. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
15. An integrated critique of the efficacy of topical mupirocin in preventing catheter-related Staphylococcus aureus infections in peritoneal dialysis clients.
Pratt O
CANNT J; 2002; 12(1):20-8. PubMed ID: 11979650
[TBL] [Abstract][Full Text] [Related]
16. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.
Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA
Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291
[TBL] [Abstract][Full Text] [Related]
17. Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery.
Shrestha NK; Banbury MK; Weber M; Cwynar RE; Lober C; Procop GW; Karafa MT; Gordon SM
Ann Thorac Surg; 2006 Jun; 81(6):2183-8. PubMed ID: 16731151
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage.
Redhead RJ; Lamb YJ; Rowsell RB
Br J Clin Pract; 1991; 45(4):252-4. PubMed ID: 1810357
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
Laupland KB; Conly JM
Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
[TBL] [Abstract][Full Text] [Related]
20. [Does nasal decontamination reduce the incidence of infections after cardiac surgery?].
Jabbour H; Madi-Jebara S; Jabbour K; Yazigi A; Haddad F; Hayek G; Yazbeck P; Antakly MC
J Med Liban; 2010; 58(2):65-70. PubMed ID: 20549891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]